You are here
Shanghai Pharma buys Cardinal Health's China business for US$557m
SHANGHAI Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for US$557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.
The deal will also help Shanghai Pharma, China
- CALL +65 6388 3838
- EMAIL email@example.com